{
    "Trade/Device Name(s)": [
        "Elecsys Vitamin D total III",
        "Elecsys Vitamin D total II"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K210901",
    "Predicate Device Reference 510(k) Number(s)": [
        "K162840"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MRG"
    ],
    "Summary Letter Date": "March 25, 2021",
    "Summary Letter Received Date": "March 26, 2021",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1825",
        "862.1825"
    ],
    "Regulation Name(s)": [
        "Vitamin D Test System",
        "System, Test, Vitamin D"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "25-hydroxyvitamin D",
        "Vitamin D3",
        "Vitamin D2",
        "24,25-dihydroxyvitamin D3",
        "3-epi-25-hydroxyvitamin D3",
        "3-epi-25-hydroxyvitamin D2",
        "1,25-dihydroxyvitamin D3",
        "1,25-dihydroxyvitamin D2"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Serum tube",
        "Serum Separation Tube (SST)",
        "Li-Heparin plasma tube",
        "K2-EDTA plasma tube",
        "K3-EDTA plasma tube",
        "Plasma Separation Tube (PST)"
    ],
    "Instrument(s)/Platform(s)": [
        "cobas e immunoassay analyzers",
        "cobas e 601 analyzer",
        "cobas c 501 analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemiluminescence binding assay",
        "Competition test principle",
        "Chemiluminescent immunoassay (ECLIA)"
    ],
    "Methodologies": [
        "Quantitative determination",
        "Binding assay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Roche Elecsys Vitamin D total III electrochemiluminescence assay for measuring 25-hydroxyvitamin D in adult serum and plasma",
    "Indications for Use Summary": "Binding assay for the in vitro quantitative determination of total 25-hydroxyvitamin D in human serum and plasma; aids in assessment of vitamin D sufficiency in adults, for use on cobas e immunoassay analyzers",
    "fda_folder": "Clinical Chemistry"
}